- Current report filing (8-K)
28 12월 2010 - 6:35AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT
OF 1934
Date of report (Date of earliest event reported): December 20, 2010
HANSEN MEDICAL, INC.
(Exact name of registrant as specified in charter)
|
|
|
|
|
Delaware
|
|
001-33151
|
|
14-1850535
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
800 East Middlefield Road
Mountain View, California 94043
(Address of principal executive offices and zip code)
Registrants
telephone number, including area code: (650) 404-5800
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On December 20, 2010, the Board of Directors (the Board) of Hansen Medical, Inc. (the Company)
approved the modification of the 2011 incentive cash bonus arrangements for Bruce J Barclay, the Companys President and Chief Executive Officer. The 2011 incentive cash bonus that Mr. Barclay would otherwise have been eligible for has
been replaced with performance-based restricted stock units or RSUs representing 120,000 shares of the Companys common stock. Such RSUs have been granted under the Companys 2006 Equity Incentive Plan and will vest based on the
Boards determination of the achievement of the Companys 2011 critical success factors as established by the Board. On December 22, 2010, Mr. Barclay agreed to this modification in the form of payment of his 2011 incentive
compensation.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
H
ANSEN
M
EDICAL
, I
NC
.
(Registrant)
|
|
|
|
|
Date: December 27, 2010
|
|
|
|
|
|
/
S
/ P
ETER
O
SBORNE
|
|
|
|
|
|
|
Peter Osborne
Interim Chief Financial Officer
|
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More News Articles